Bearmind, a sports tech company, has introduced an innovative brain health monitoring device for athletes, designed to transform how sports teams track and manage head impact risks. The product, a helmet insert equipped with advanced sensors, continuously monitors impacts to an athlete’s head, sending real-time data to a secure cloud platform. Here, Bearmind’s proprietary algorithms analyze the data, providing sports teams and medical staff with instant insights into both immediate impacts and long-term brain health risks.

The technology aims to address a major concern in contact sports, such as football, rugby, and hockey, by helping teams make informed decisions to protect players from traumatic brain injuries (TBIs) and concussions. In addition to real-time monitoring, the system tracks cumulative impacts, identifying players who may be at higher risk over time.

About Bearmind

Bearmind is dedicated to advancing athlete safety through cutting-edge wearable tech. The startup has already conducted successful trials with teams in Europe and the U.S., and has received enthusiastic feedback for its data-driven approach to sports safety. By combining sports science with practical technology, Bearmind is on a mission to set new standards in brain health monitoring and make sports safer for athletes worldwide.

A tiny chip with a special surface can precisely identify the blood biomarkers of a heart attack in a matter of minutes, even if they are at very low concentrations. The device's creators envision it being used as a diagnostic tool at home.

Time is of the essence when dealing with a heart attack. Patient outcomes are improved by early diagnosis because less damage is done and blood flow is restored to the heart more quickly. However, heart attacks are cunning creatures, with symptoms that vary from person to person.

Researchers at Johns Hopkins University (JHU) have led the design of a tiny chip that diagnoses heart attack by detecting important biomarkers in minutes rather than hours, even if they are present at very low concentrations, reports Paul McClure in New Atlas.

The proof-of-concept work, which can be modified to detect infectious diseases and cancer biomarkers, is newly published in Advanced Science.

"Heart attacks require immediate medical intervention in order to improve patient outcomes, but while early diagnosis is critical, it can also be very challenging—and near impossible outside of a clinical setting," said lead author Peng Zheng, an assistant research scientist at Johns Hopkins University. "We were able to invent a new technology that can quickly and accurately establish if someone is having a heart attack."

Related Ultrasound Wearable Patch Could Provide Early Warning for Heart Attacks and Strokes

Zheng and senior author Ishan Barman use biophotonics to create diagnostic tools that use laser light to find biomarkers, which are the body's reactions to various conditions, including disease. Here, they employed technology to detect the first indications of a heart attack in the blood. Heart attacks continue to be one of the most difficult conditions to diagnose; symptoms vary greatly and biological signs can be subtle and easy to miss in the early stages of a heart attack. In the United States, more than 8000,000 people have heart attacks every year.

The stand-alone blood test the team created provides results in five to seven minutes. It's also more accurate and more affordable than current methods, the researchers say.

Though created for speedy diagnostic work in a clinical setting, the test could be adapted as a hand-held tool that first responders could use in the field, or that people might even be able to use themselves at home.

"We're talking about speed, we're talking about accuracy, and we're talking of the ability to perform measurements outside of a hospital," said Barman, a bioengineer in JHU's Department of Mechanical Engineering. "In the future we hope this could be made into a hand-held instrument like a Star Trek tricorder, where you have a drop of blood and then, voilà, in a few seconds you have detection."

“We developed this sensor to collect physiological data, information including ECG, heart rate, respiration, and body temperature,” said Jenny Tseng, Singular Wing’s marketing specialist, when New Atlas spoke with her at the expo. “And at this exhibition, we display the glucose monitoring. So, we use ECG to estimate the glucose level for high, medium, and low glucose level.”

Used to diagnose problems with heart rate or rhythm, an ECG is a non-invasive method of reading the electrical activity of the heart. In a medical setting, it might involve applying several tiny gel pads to the arms, legs, and chest and having the patient lie motionless for a minute or so. Naturally, a lot of wearable technology now continuously tracks a user's heart rhythm and rate, reports Paul McClure in New Atlas.

Research has demonstrated that both hypoglycemia and hyperglycemia impact the electrical properties of the heart, resulting in specific alterations that are visible on an electrocardiogram. In order to reliably forecast blood sugar, researchers have employed machine learning to analyze ECGs and create algorithms based on those data.

Related South Korean CGM Receives Regulatory Approval

While the product is still under development, Singular Wings has done the same with their non-invasive CGM.

“Because we use machine learning method and … the accuracy, the average accuracy, I can tell you, is about 80%,” said Dick Hsieh, PhD, account manager for Singular Wings. “But it’s about model training. We still need [a] validation stage. But the result of [the] validation stage, it is [at] the moment unknown.”

An attention-deficit hyperactivity disorder (ADHD) video game 'test' that uses a wearable, non-invasive brain-computer interface (BCI) to rapidly measure neural activity while the user plays is helping doctors make more accurate diagnoses. This new idea has great potential to eliminate the gray area around the diagnosis of ADHD, even if it is still in the research stage.

Currently, mental and behavioral evaluations are the main methods of diagnosis until further research on genetic biomarkers for ADHD is conducted. According to the Mayo Clinic, three distinct forms of ADHD are identified based on symptoms: mostly inattentive, primarily hyperactive/impulsive, and combined or mixed—where a person falls on the wide and diverse continuum between these two.

Related Neuralink Implants Brain Chip in Human

Even though EEG can now be used to measure brain activity for ADHD diagnoses, it ignores this resting/task state and fails to recognize the subtleties of the condition's subtypes, which are, predictably, complicated and highly diverse when it comes to mixed type ADHD.

Researchers from Taiwan’s National Yang Ming Chiao Tung University (NYCY) developed a wireless BCI device that fits comfortably on a patient's head to record both resting-state and 'task-state' electroencephalography (EEG) signals.

This BCI works in conjunction with a game or video designed to stimulate a visual and auditory response in the patient, and information from the brain is transmitted from each dry EEG electrode in different channels to specially designed AI-assisted software, reports Bronwyn Thompson in New Atlas.

"It's convenient and time-saving – it only takes 10 minutes to put on this device," explained researcher Jo-Wei Lin at Taiwan's Innotech Expo on October 18. "For children, traditional ADHD diagnosis needs many interviews with teachers and parents, and questionnaires to decide whether the child has ADHD or not.

The device serves as an extra tool to precisely diagnose and treat ADHD, but it is not intended to take the role of medical professionals. Although children have been the focus of the research, the team claims that adults can adapt to the way brainwave processing functions.

Compared to questionnaires and interviews, the game-based test feels more approachable to children and is a new addition to the evaluation of ADHD. Additionally, in collaboration with Kaohsiung Chang Gung Memorial Hospital and Hsinchu Ton Yen General Hospital, the team's equipment has a 95% accuracy rate.

“We let the children wear the testing device to play the ‘game-based attention test’ by the research team," said team lead Li-Wei Ko, professor of the Institute of Electrical and Control Engineering at NYCU, in September. "At the same time, we analyze their brainwave changes to determine whether they tend to hyperactivity, which can shorten the traditional diagnostic process that takes three months to one month."

Early research into the technology was published in the Journal of Neural Engineering.

Brighton, UK-based Emteq Labs unveiled Sense, the world’s first emotion-sensing smart glasses. Alongside the unveiling of Sense, the company announced the appointment of Steen Strand, former head of the hardware division of Snap Inc., as its new Chief Executive Officer.

The new AI-powered eyewear platform provides lab-quality insights in real life and in real time. This includes comprehensive measurement and analysis of the wearer’s facial expressions, dietary habits, mood, posture, attention levels, physical activity, and additional health-related metrics, Emteq said in a press release.

“Our faces reveal deep insights about our minds and bodies. Since founding Emteq Labs in 2015, we have been on a mission to improve lives and health outcomes through a deeper understanding of our emotional responses and behaviors,” said Dr. Charles Nduka, founder and Chief Science Officer at Emteq Labs. “Our proven, breakthrough Sense eyewear allows us to look inward, rather than outward. Wearers will peer into the future to see how subtle, nearly invisible factors can shape long-term health and wellness like never before.”

Emteq’s Sense glasses are equipped with contactless OCO sensors that detect high-resolution facial activations at key muscle locations, as well as a downward-facing camera for instantly logging food consumption. Data collected is analyzed using proprietary AI/ML algorithms, and securely transferred to the Sense app and cloud platform. The user has full control over the data and can choose to share it with researchers, trainers, coaches, or clinicians upon consent.

Related UK MOD Picks XRAI to Help Hearing Impaired Employees

The powerful insights that Sense uncovers have a transformative impact on weight management and mental health, as well as broader healthcare applications, consumer sentiment, augmented reality, and more.

According to the World Health Organization, more than 1 billion people in the world are living with obesity and approximately 970 million people worldwide are living with a mental health disorder. Emteq’s platform helps address these critical health issues by enabling a deeper understanding of everyday behaviors, decisions, and the emotions that drive them.

A recent peer-reviewed study in the Journal of Medical Internal Research found that Sense accurately tracks food intake and eating behavior in everyday settings, overcoming the major limitations of traditional self-reporting methods such as manual food logs. This research confirms the effectiveness of Emteq’s technology for precise dietary monitoring, which is essential for successful interventions to promote a healthy lifestyle.

Additionally, research published in Frontiers in Psychiatry journal demonstrated that Emteq’s platform can distinguish between depressed and non-depressed people as compared with current gold standard diagnostic methods. By effectively assessing affective behaviors in remote settings – such as the home, office, or school – Sense is poised to significantly improve the diagnosis and monitoring of chronic mental health and neurological conditions including depression, anxiety, autism spectrum disorder, and more.

"Having spent my entire career at the intersection of innovation and consumer products, I can confidently assert that Emteq will transform the smart eyewear landscape and, more importantly, improve and save lives," said Steen Strand, CEO of Emteq Labs. "Health applications have catalyzed the rise of wearables, and eyewear is the next frontier. Emteq will deliver the most compelling case for smart glasses yet—proving that they can dramatically improve your health."

Prior to joining Emteq, Strand led Snap Inc.'s hardware division, SnapLab, where he was responsible for the Spectacles line of augmented reality eyewear as well as the company’s hardware-related investments and acquisitions.

Emteq Labs’ Sense development kit will be available to commercial partners tackling a wide range of applications starting in December.

About Emteq Labs

Emteq Labs is a UK-based deep technology company pioneering real-time emotion recognition in virtual and augmented environments. The company’s patented emotion-sensing eyewear captures facial muscle activity across diverse settings, leveraging proprietary AI/ML algorithms to provide insights on expressions, eating behaviors, attention and physical activity. With nearly a decade of research backing its innovations, Emteq Labs holds 27 patents, has published 28 peer-reviewed publications, and has earned multiple awards for its cutting-edge technology.

At its annual Connect conference on Wednesday, Facebook's parent company Meta Platforms unveiled Orion, the first functional prototype of augmented reality glasses. The California company outlined its goals for products that would bring the virtual and physical worlds together.

"This is the physical world with holograms overlaid on it," Chief Executive Mark Zuckerberg said after pulling out the chunky black glasses from a metal case dramatically brought to him on stage.

"For now, I think the right way to look at Orion is as a time machine," he said. "These glasses exist, they are awesome and they are a glimpse of a future that I think is going to be pretty exciting."

Related Meta’s New AI Tool for Music Generation

Orion is the most sophisticated AR glasses that Meta has produced to date, fusing the immersive qualities of augmented reality with the appearance and feel of a standard set of glasses.

The glasses are powered by specially engineered silicon that was created by Meta and are composed of magnesium alloy. Through voice, hand-tracking, and a neural interface based on the wrist, users will be able to communicate with the glasses.

The glasses combine cutting-edge augmented reality technologies that project 2D and 3D content directly into the user's surroundings with transparent lenses that allow users to maintain eye contact and monitor their surroundings. Orion's release, according to Meta, is a step toward accomplishing a major objective: making sure users are no longer forced to choose between being present in their actual environment and receiving digital information, reports Auganix.

According to Zuckerberg, Meta intends to focus on making it more affordable, sleeker, and smaller before selling it to customers.

According to Meta, there are three primary reasons why AR glasses are key to unlocking the next great leap in human-oriented computing.

• They enable digital experiences that are unconstrained by the limits of a smartphone screen. With large holographic displays, you can use the physical world as your canvas, placing 2D and 3D content and experiences anywhere you want.

• They seamlessly integrate contextual AI that can sense and understand the world around you in order to anticipate and proactively address your needs.

• They’re lightweight and great for both indoor and outdoor use, and they let people see each other’s face, eyes and expressions.

Meta also unveiled a new Quest mixed-reality headset and additional AI chatbot features for its services. On Wednesday, Meta's stock hit a record closing high of $568.31, up 0.9%.

Chinese researchers have developed a suture that electrically stimulates the wound when it is under tension, as happens during movement.

The most common therapy for deep and big skin wounds is sutures, which physically reunite the cells on each side of the wound to allow them to repair the damage. In their absence, injuries have a higher chance of infection, heal more slowly, and leave bigger scars.

However, they have some issues of their own. They can be opened by movement of the affected area, and once they have served their purpose, doctors typically need to remove them. Researchers at China's Donghua University have found solutions to both of those issues in a recent study.

A specific mechanoelectrical fiber is used to create the new sutures. In essence, electric fields are created when the fiber's core and sheath layers come into contact and split apart due to movement; this has been demonstrated in earlier studies to hasten healing.

Rats with wounds and artificial muscle fibers were used in a number of studies the researchers conducted with the suture, reports Guardian.

The findings show that its components get electrically charged when the sutures are stretched and the core moves inside the sheath; this is the same process that happens, for instance, when a balloon is rubbed against hair.

“The suture generates electricity by creating opposite charges on the suture’s middle and outer shell when muscles relax and contract, based on the triboelectric effect,” Hou said. “This generates an electric field at the wound site to accelerate wound healing.”

Related This Smart Bandage Provides Wound Report in Real-Time

While movement can strain and hinder how well traditional stitches work, it can be a benefit for the new sutures.

Through research in a petri dish, the scientists discovered that the presence of an electrical field enhanced the rates at which cells multiplied and moved to the area surrounding the sutures, while electrical stimulation also decreased the growth of bacteria.

In their experiments with rats, the researchers also discovered that cuts in their muscles held together with the new sutures had fewer bacteria and healed more quickly than those stitched with regular bioabsorbable sutures. The team notes that this is significant in lowering the risk of postoperative infections.

Compared to when no sutures or alternative bioabsorbable sutures were used, the wounds were nearly fully healed after ten days. "This suture can help wounds heal faster by almost 50% by creating an electric field through the object's natural movements," according to Hou's tests on rats.

Happy Health, an innovative health technology company based in Austin, TX, has received FDA clearance for its groundbreaking consumer-focused platform designed to bring clinical-grade healthcare directly into the home. At the heart of this revolution is the Happy Ring – the first and only truly wearable medical device that seamlessly combines medical accuracy with all-day comfort.

Accuracy Meets Wearability

The Happy Ring is designed to monitor key health metrics such as sleep, blood oxygen, heart rate, activity, temperature, brain activity, and more - all while fitting comfortably on your finger. With a near-indestructible, diamond-hard ceramic design, the Happy Ring has been recognized by the IDSA with its prestigious Design Award, the company said in a press release.

"We're inundated today with wearable devices that are invalidated and inaccurate, leading to poor decision-making and, ultimately, anxiety. Imagine driving down a remote highway with a fuel gauge that's constantly fluctuating and faulty. Instead of providing reassurance, it leaves you frustrated. This is the reality for many people relying on today's wearables for health decision making. We're here to change that,” says Dr. Dustin Freckleton, CEO of Happy Health.

The Future of Healthcare

Happy Health's platform goes beyond just the Happy Ring and associated devices. It's a comprehensive diagnostic and ongoing clinical monitoring solution that uses personalized machine learning algorithms and generative AI to integrate data into a clinical context where it matters most. With Happy, data becomes more than numbers on a screen – it's translated into actionable notifications and alerts sent directly to patients and their care teams. This full-circle approach allows individuals to receive coordinated clinical monitoring for a wide range of health conditions – from sleep apnea and heart disease to diabetes, obesity, hypertension, and more.

Related England Players Wearing Smart Rings to Boost Euro Hopes

Patient-Driven, Doctor-Powered Healthcare

Happy Health's platform empowers individuals with health data and clinical expertise, literally at their fingertips, allowing them to take charge of their own health journey right from the comfort of their home.

Happy Sleep

Happy Health's first clinical program, Happy Sleep, is set to launch later this year, offering an all-encompassing approach to sleep health. The Happy Ring will be available directly to consumers at launch through the Happy Sleep website as well as through partnerships with hospital systems, physician groups, and other medical service providers.

About Happy Health

Based in Austin, TX, Happy Health is pioneering the future of healthcare by creating a consumer-first healthcare experience that is patient-driven and doctor-powered. Through its novel platform, Happy Health empowers individuals to take charge of their health with accurate, actionable data and clinical expertise, right at home.

AR software solutions provider XRAI has been selected to supply AR glasses as part of a pilot program aimed at enhancing accessibility for employees with hearing impairments within the UK Ministry of Defence (MOD).

The three-month-long pilot program is being conducted in Bristol's MOD Abbey Wood. Eight sets of AR glasses, supplied by XRAI Glass under a £10,000 contract, are among the first to be tested by staff members of the Defence Equipment & Support (DE&S) company. Under a £10,000 contract with XRAI Glass, the Defence Equipment & Support (DE&S) organization is one of the first to test the technology, which comprises eight sets of AR glasses, reports Auganix.‍

Users wearing phone-tethered augmented reality (AR) smart glasses will be able to read speech in real-time through closed captioning. The XRAI Glass software converts audio into a subtitled version of conversation which will then appear on the user’s glasses screen. The software’s sophisticated voice recognition capabilities can identify who’s speaking and will soon have the power to translate languages, voice tones, accents, and pitch.

Related These AR Glasses Can Translate Languages and Detect Images

Steve Crump, Founder and Chair, DeafKidz International, said: “As a profoundly deaf person myself, I was blown away by this technology. When I tried on the glasses, I was astonished – real time subtitles that enable you to engage and participate as never before. I see XRAI Glass as a hugely positive force, and I can’t wait to work with the team to help bring this to life.”

The trial is being led by Chris Chennell, a senior architect on the DE&S Digital delivery team. Chennell stated: “The initial feedback has been really encouraging, and I’m very hopeful this will prove to be a really positive addition for our staff. The next three months will gather more feedback to help us determine the best way to assist our colleagues with hearing loss, whether it’s through this technology or something else.”

DE&S said that if the trial is successful, the goal would be to make the glasses available throughout the MOD and possibly other government agencies.

Snap doubled down on its prediction that wearable electronics that improves one's vision of the actual world will be among the next big things in the IT industry on Tuesday by announcing an updated version of its Spectacles augmented-reality glasses.

Snap, well-known for its fleeting messaging service and animated filters, was a pioneer in augmented reality, a technology that allows users to superimpose virtual effects on images or videos taken of real-world scenes using a camera or lens.

Related Portable Google TV Experience for XR Glasses

The new fifth generation Spectacles integrate with mobile devices through the new Spectacles app, allowing users to control Lenses, mirror their phone screens, use their phone as a gaming controller with Lenses, and enable a spectator mode that allows people without their own Spectacles to follow along.

Compared to earlier models, the glasses offer a wider field of view and automatically darken in direct sunlight.

Initially, developers who create augmented reality features would be able to purchase spectacles for $99 a month, rather than selling them to consumers, reports Reuters.

In an interview conducted prior to the summit, Spiegel stated that this is a crucial step in increasing adoption among regular users.

"There has to be really compelling experiences," he said. "By working really closely with developers and just continuously improving our platform, I think we're going to get to a place where there are a lot of compelling lenses for people to try with Spectacles."

According to Snap, developers will be able to create more engaging augmented reality experiences for groups of two or more Spectacles wearers with the new OS. For instance, chess might be played in real time between two users in the same room on a virtual board that is rendered in the players' environment.

Additionally, Snap announced a revamp of the Snapchat app, condensing it from five distinct parts to three. In the past, the firm streamlined Snapchat's user interface for ads in an effort to boost advertising results.

One of the biggest obstacles for those who wear prosthetic limbs is learning to control the device so that it moves like a real limb. Electromyography, a technique for recording electrical activity from the muscles, is used to control the majority of prosthetic limbs; nevertheless, this method only offers restricted control over the prosthesis.

A research team from the BioRobotics Institute of the Scuola Superiore Sant'Anna in Pisa, coordinated by Prof. Christian Cipriani, has developed an alternative approach that could offer much more precise control of prosthetic limbs. They created the first prosthetic hand controlled by magnets, enabling amputees to move it by thought.

First, the researchers used MRI scans and electromyography, which measures electrical activity in muscle tissue, to ascertain how Daniel's left arm stump's muscles tightened as he imagined manipulating the fingers of his missing hand. Daniel was a suitable candidate in part because he was already suffering from phantom limb sensation, a typical condition in which amputees continue to sense the presence of a missing limb, reports NewAtlas.

The researchers inserted six tiny magnets, each measuring only a few millimeters, into a handful of the major muscles in accordance with their observations. Daniel was then supplied with a prosthetic hand called Mia-Hand, which came with a carbon fiber cuff that he wore over his arm stump.

Related Mind-Controlled Prosthetic Legs Enable Faster, Natural Walk

Magnetic field sensors in the cuff picked up the matching movements of the implanted magnets as the muscles in that arm contracted in response to his thoughts about moving his fingers. The hand's fingers were stimulated to move in the corresponding manner based on which magnets and muscles were moving in which direction.

In the tests conducted thus far, Daniel has opened jars, used screwdrivers, closed zip-lock bags, cut with a knife, and lifted and moved a variety of objects with his hand. Additionally, he demonstrated the ability to control how hard he grasped fragile objects.

"The trial on the first patient was successful," says Cipriani. "We are ready to extend these results to a broader range of amputations."

The results of the trial were presented in the scientific journal Science Robotics and represent a significant step forward for the future of prostheses. “This result rewards a decades-long research path. We have finally developed a functional prosthesis that meets the needs of a person who has lost a hand” says Prof. Cipriani.

New reusable medical patch with octopus-shaped suckers that adhere to the skin can track a number of vital signs and perhaps stop the skin irritations, blisters, rips, and tension injuries brought on by conventional adhesive patches.

“The patch is designed for easy removal without causing discomfort or pain, unlike conventional glue-based patches,” says Nazek El-Atab, who led the team that developed it.  “Our goal is to develop a comprehensive, versatile, skin-attachable device that can revolutionize wearable health monitoring and diagnostic technologies.”

Medical professionals frequently use adhesive patches to attach medical equipment to patients. These devices could be used to give essential medications through the skin or to record things like muscle reaction or pulse rate. Many patches rely on chemical adhesives; however, these glues can produce a range of negative effects for the skin, reports Aljawharah Alsharif in KAUST Discovery.

The round suckers that octopuses have on their limbs have inspired KAUST researchers to produce a quick and inexpensive method of producing medical patches that contain "adhesive miniaturized octopus-like suckers" (AMOS). The biocompatible, breathable, flexible patches have an electrode that can track many types of biosignal.

Related Performance Challenges in Skin-Interfaced Electronics

“Previous bioinspired suction-based adhesives have suffered primarily from limited manufacturing flexibility and versatility due to traditional nano-/microfabrication techniques,” explains Aljawharah A. Alsharif, a Ph.D. student under the supervision of El-Atab.

“Other bio-inspired patches that adhere using suction mechanisms tend to face challenges when it comes to manufacturing: traditional nano-/microfabrication techniques limit the required manufacturing flexibility and versatility to produce them. Typically, these adhesives feature tiny hollows or ridges measured in millionths or even billionths of a meter and so fabricating materials with these finely detailed structures can be expensive. Also, they may only be effective on certain types of skin surface.

According to Alsharif, the AMOS patch uses a quick hybrid 3D printing method to overcome these restrictions. The researchers discovered that stereolithography, a method of 3D printing, might provide the accuracy required to create the AMOS patches. The process involves precisely building up a resin mold with small domes and wavy lines using an ultraviolet laser. Subsequently, they employed that mold to fabricate an AMOS patch using polydimethylsiloxane (PDMS), a biocompatible polymer with a naturally occurring stickiness.

They discovered that patches with 200 micrometer-wide suckers provided the best adherence after testing patches with varied sucker sizes and patterns. In the meantime, the material of the patch is very breathable because of its wiggly grooves, which aid in allowing moisture to escape from the skin. According to Alsharif, "the suckers in the patch create a vacuum when it is lightly pressed on the skin, providing secure adhesion even under various skin conditions such as dry, wet, or hairy surfaces." The same patch can be applied again and again thanks to this technique of adhesion, which makes it helpful for long-term health monitoring.

The researchers fitted the patch with electrodes, attached it to the hairy chest of a male volunteer while he cycled on an exercise bike, and used the device to monitor the subject’s electrocardiogram (ECG) signals. The same patch could also be placed on different parts of the body to record electromyograms (EMG) — which measure muscle response — and electrooculograms (EOG) to monitor eye movements.

Digital Health is becoming a more adopted form of treatment in the healthcare industry because it reduces barriers to patients receiving effective care from providers. With Ambiq enabling energy-efficient edge AI, the adoption of digital health devices will continue to grow as patients and providers can count on longer-lasting batteries, enhanced privacy and security, and increased robustness thanks to local computing that doesn’t rely on a strong connection to the Cloud.

Ambiq is a semiconductor and solutions company that enables low-power edge AI using its core technology, the Subthreshold Power Optimization Technology platform or SPOT. In traditional circuit design, voltage levels are represented as 1 and 0 with any voltages above 1 as on, and anything below 1 as off. The reason why it turns off is because it is hard to control variables such as temperature, voltage fluctuations, or hardware variations outside a laboratory. However, Ambiq’s SPOT technology has solved these problems at scale, enabling edge AI devices to operate at voltage levels as low as 0.3 volts – a quadratic savings in battery consumption.

Utilizing SPOT, digital health devices can extract meaningful insights about a patient's health because these digital health devices will always be running wherever they are. Users don’t need to constantly be plugged into an outlet because the digital health device is performing computing on the local device. Patients are not sending large amounts of raw data to the cloud, which keeps power-hungry radios powered on longer.

Patients can expect ease of use because of the robustness of the SPOT platform. Because these digital health devices are computed locally, the quality of speed or connection to the cloud is not a factor in receiving real-time, instant data when the patient needs it. They can also expect their digital health device to provide more finetuned and personalized data.

Finally, patients can feel confident in their decision to use digital health at the edge to monitor their vitals, as it comes with enhanced privacy and security. Private and raw data will be kept out of the Cloud, ensuring no one but the patient and those they choose to share with knows this sensitive information. Keeping the data on the device will also keep it from cyber thieves who breach the Cloud and use the patient's personal information for their own gain.

SPOT and Digital health go together, and as the world looks to integrate AI into our daily lives, Edge AI enabled by Ambiq will become the new standard in creating meaningful applications of how patients diagnose and receive care.

For more information, visit Ambiq at Medica on November 11-14, 2024, in Dusseldorf, Germany (Book Meeting with Ambiq at Medica). They will be located at booth number 13C59 in Hall 13, where visitors can get more hands-on experience with AI models in digital health running on their ultra-low-powered microcontrollers and Systems-on-Chips.

About Ambiq    

Ambiq’s mission is to develop the lowest-power semiconductor solutions to enable intelligent devices everywhere and drive a more energy-efficient, sustainable, and data-driven world. Ambiq has helped leading manufacturers worldwide create products that last weeks on a single charge (rather than days) while delivering a maximum feature set in compact industrial designs. Ambiq’s goal is to take Artificial Intelligence (AI) where it has never gone before in mobile and portable devices, using Ambiq’s advanced ultra-low power system on chip (SoC) solutions. Ambiq has shipped more than 250 million units.    

Take a look at the heartKIT Demo Video here!

It should come as no surprise that a few different businesses are already selling electric inline skates, sometimes known as rollerblades. But what makes the AtmosGear skates special is that the user wears the battery around their waist.

The AtmosGears are manufactured by the French business AtmosGear, and are currently the focus of a Kickstarter campaign.

According to the company, “The idea was born in 2009, after watching Air Gear: a legendary Japanese Anime with characters riding electric rollerblades. They were so fast they could literally FLY over buildings in Tokyo!”

Mido, the founder, was only 12 at the time and he LOVED skating so much that he decided he was going to become an engineer, to make his dream a reality.  And, ten years later, Mido finally got into engineering school so he started prototyping. He founded AtmosGear in 2018, while still a student and even managed to hire interns to assist him, reports NewAtlas.

What makes the skates themselves special is a hub motor in the middle wheel of each one. Both motors of the rollerblades are driven by a single 280-Wh lithium-ion battery that is carried in an accompanying 3-lb (1.5-kg) fanny pack. Two different coiled cords connect that battery to each skate's middle wheel in a setup that could get a little complicated. A wireless remote that comes with the package has a thumb-switch throttle for operating the motors.

Related With The Next Gen Of Wearables, Athletes Will Alter The Way They Fuel For Sport

Moving the battery out of the skates, according to the designers, makes them lighter and more manoeuvrable (each frame reportedly weighs just 1.5 lb, or 680 g) more than a regular one. It also lessens the chance that the battery will be harmed by the skates' constant pounding of the asphalt.

Additionally, the AtmosGears can be used as regular old unpowered rollerblades if the wires are cut out and the fanny pack is not used. Releasing the throttle on the remote leads them to go into unpowered mode even when they are connected. It's worth noting that the remote control has the ability to perform electronic braking and reverse motion.

In terms of specifications, the skates are said to have a range of 16 miles (26 km) between charges and a maximum speed of 18 mph (29 km/h). They can support persons weighing up to 260 lb (118 kg) and create enough torque to climb 15% gradients. Because their electronics are IP65 water-resistant, low-pressure water jets coming from all directions can't harm them.

If all goes according to plan, a pledge of €630 (about US$700) will bring you a pair of frames that you may wear with your own boots; a combination of boots and frames will cost €770 ($860). Retail costs of $850 and $1,000, respectively, are expected.

Apple unveiled breakthrough sleep and hearing health features coming to Apple Watch and AirPods Pro 2 that further deliver on Apple’s commitment to health with experiences that enrich users’ lives. These new features expand across products, bringing informative and powerful ways to support users in their sleep and hearing health for conditions that impact billions globally.

Using an innovative new Breathing Disturbances metric, sleep apnea notifications come to Apple Watch, adding to the many ways Apple Watch acts as an intelligent guardian for users’ health. The sleep apnea notifications are expected to receive marketing authorization from the Food and Drug Administration (FDA) and other global health authorities soon, with availability this month in more than 150 countries and regions, including the U.S., the EU, and Japan, Apple said in a press release.

“At Apple, we believe that technology can help you live a healthier life, and we’re excited to enable incredible new health capabilities for serious conditions that affect billions of people around the world, while continuing to keep user data private,” said Sumbul Desai, M.D., Apple’s vice president of Health. “With Apple Watch, we continue to offer our users the ability to uncover important health conditions with new sleep apnea notifications. And on AirPods Pro, powerful features put users’ hearing health front and center, bringing new ways to help test for and receive assistance for hearing loss.”

A Powerful Way to Detect Signs of Sleep Apnea

Sleep is an important area of health as it impacts a person’s overall physical and mental wellbeing. Sleep apnea is a prevalent disorder in which breathing momentarily stops during sleep, preventing the body from getting enough oxygen. The condition is estimated to impact more than 1 billion people worldwide, and in most cases, goes undiagnosed. If left untreated, it can have important health consequences over time, including increased risk of hypertension, type 2 diabetes, and cardiac issues.

Related Apple Vision Pro Can Now Control Brain Implant

Breathing Disturbances is an innovative new Apple Watch metric that uses the accelerometer to detect small movements at the wrist associated with interruptions to normal respiratory patterns during sleep. Every 30 days, Apple Watch will analyze breathing disturbance data and notify users if it shows consistent signs of moderate to severe sleep apnea so they can speak to their doctor about next steps, including potential diagnosis and treatment.

The World’s First All-in-One Hearing Health Experience

Approximately 1.5 billion people around the world are living with hearing loss, according to the World Health Organization. Research has also identified links between hearing loss and impact on a person’s overall wellbeing, including dementia and social isolation.

To help users better understand their hearing health, Apple is introducing an end-to-end experience focused on prevention, awareness, and assistance.

In order to help users prevent exposure to loud environmental noise while preserving the sound signature of what they’re listening to, Hearing Protection comes to AirPods Pro. The ear tips help to provide passive noise reduction, while the H2 chip helps to actively reduce louder, more intermittent noise at 48,000 times per second. On by default across all listening modes, Hearing Protection is helpful in a variety of loud settings. Plus, with an all-new multiband high dynamic range algorithm, sounds at live events like concerts remain natural and vibrant.

Apple is also introducing an intuitive, clinical-grade hearing test based on the standard clinical approach called pure-tone audiometry that users can take themselves with their AirPods Pro and a compatible iPhone or iPad.

Users can take the convenient test in about five minutes from the comfort of their own home. The Hearing Test feature leverages advanced acoustic science and provides users with an interactive experience.

After taking the Hearing Test, the user’s hearing profile can also help to personalize the AirPods Pro listening experience for even more people, including those with little to no hearing loss who can still benefit from specific adjustments at individual frequencies.

Elon Musk's brain-chip startup Neuralink has received FDA breakthrough device designation for Blindsight, an implant that aims to restore vision in individuals who are blind.

According to Musk, the device, called “Blindsight,” will allow people who have lost both eyes and their optic nerve to see as long as the visual cortex — the part of the brain that receives and processes visual information relayed from the eyes— is intact.

“The Blindsight device from Neuralink will enable even those who have lost both eyes and their optic nerve to see,” Musk wrote on X on Tuesday. “Provided the visual cortex is intact, it will even enable those who have been blind from birth to see for the first time.”

The FDA's breakthrough tag is given to certain medical devices that provide treatment or diagnosis of life-threatening conditions. It is aimed at speeding up development and review of devices currently under development, reports New York Post.

According to the agency's website, the "breakthrough device" program aims to "speed up development, assessment and review for premarket approval" for medical devices that treat permanent or life-threatening illnesses, provided that they follow safety criteria.

“To set expectations correctly, the vision will be at first be low resolution, like Atari graphics, but eventually it has the potential be better than natural vision and enable you to see in infrared, ultraviolet or even radar wavelengths, like Geordi La Forge,” Musk added.

Related This Wearable Lets Blind People See

Neuralink is developing a brain chip interface that can be implanted inside the skull. Founded in 2016 by Musk and a team of engineers, the company claims that this technology might eventually let crippled patients move and speak again as well as restore their vision.

The device from Neuralink contains a chip that can process and send neural signals to other devices, such as a phone or computer.
Earlier this year, Neuralink completed its first successful device implantation in a patient, who has since used the company's BCI for various applications, including playing video games and online chess.

Last year, the company received FDA approval to move from animal and human testing of its BCI device.

DexCom, the global leader in real-time continuous glucose monitoring for people with diabetes, announced today that Stelo, the first over-the-counter glucose biosensor in the U.S., is now available for purchase without a prescription via the company’s website.

Stelo is a small biosensor worn on the back of the upper arm that leverages Dexcom’s most accurate glucose sensing technology. It is specifically designed to provide the 125 million Americans 6 with Type 2 diabetes not using insulin and those with prediabetes with powerful, personalized glucose insights sent directly to a smartphone, revealing how food, exercise and sleep can affect glucose – all without painful fingersticks, Dexcom said in a press release.

“Dexcom has been at the forefront of glucose biosensing for 25 years. With the launch of Stelo, we’re defining a brand-new category and once again setting the gold standard for people to easily take control of their health,” said Jake Leach, executive vice president and chief operating officer at Dexcom. “Now, millions more have access to 24/7, easy-to-understand glucose insights that can inform their daily lifestyle choices and support behavior modification.”

The benefits of glucose biosensing have been shown when used alone, or alongside other diabetes and weight management medications. 7 Studies show the use of Dexcom glucose biosensing by people with Type 2 diabetes is associated with clinically meaningful improvement in time in range, A1c and quality of life.

Related Abbott Receives FDA Clearance for Two CGMs

“Dexcom glucose biosensors are an essential and proven tool for diabetes management – driving strong clinical outcomes regardless of medication use 9 and even potentially slowing the progression of diabetes,” said Thomas Grace, MD, head of clinical advocacy and outcomes at Dexcom. “In a world where GLP-1 use is becoming increasingly more common, glucose biosensors like Stelo can help make those medications more effective.”

Key features of Stelo

• No fingersticks, ever: The only over-the-counter glucose biosensor designed for people with diabetes that doesn’t require any fingersticks.

• Up to 15-day wear time and waterproof: The longest biosensor wear time on the market ‡ with the highest waterproof rating.

• A personalized, easy-to-use app: Provides daily, weekly and session summary insights that can help form healthier habits.

• Spike and pattern detection: The only over-the-counter glucose biosensor for people with diabetes featuring spike detection, designed to identify meaningful glucose variability as it happens so users can make informed changes.

• Proven results with Dexcom glucose sensors: Using Dexcom glucose sensors like Stelo helps lower A1c for people with Type 2 diabetes and may help slow the progression of diabetes. Only Dexcom glucose sensors have been associated with significant improvements in glucose and cardiovascular risk reduction measures as early as three months.

Effortless ordering, delivered directly to your door

Stelo improves access to critical health technology for people with Type 2 diabetes not using insulin and those with prediabetes who might not have insurance coverage for prescription glucose biosensors. Stelo is currently available for purchase in the U.S. at Stelo.com and is FSA and HSA eligible.

• Pay-as-you-go: Pay $99 for a single pack of two sensors (total wear time up to 30 days).
• Monthly subscription: Subscribe and save 10%. Pay $89 per month for an ongoing subscription, with two sensors (total wear time up to 30 days) delivered every 30 days.

Stelo is now part of Dexcom’s overall portfolio of glucose biosensors, with a user base of more than 2.5 million people globally. The Dexcom portfolio in the U.S. consists of the Dexcom G6 and Dexcom G7 Continuous Glucose Monitoring Systems, and now Stelo, collectively designed to address the needs of people with all types of diabetes and prediabetes.

About DexCom, Inc.

DexCom, Inc. empowers people to take control of health through innovative continuous glucose monitoring (CGM) systems. Headquartered in San Diego, Calif., and with operations across Europe and select parts of Asia/Oceania, Dexcom has emerged as a leader of diabetes care technology. By listening to the needs of users, caregivers and providers, Dexcom works to simplify and improve diabetes management around the world.

Even Realities has unveiled its highly anticipated G1 Smart Glasses, marking a new era in augmented reality (AR) innovation. The G1 promises to deliver a seamless blend of immersive digital experiences with the physical world, targeting tech enthusiasts, professionals, and gamers alike.

A Leap in AR Technology

The G1 Smart Glasses stand out with their lightweight, ergonomic design, offering users a more comfortable and versatile experience compared to previous AR glasses. Even Realities has prioritized both style and functionality, making the G1 a fashion-forward device that users can wear all day without discomfort.

Key to the G1's appeal is its crystal-clear optics and high-definition display, providing an unrivaled field of view. The smart glasses come equipped with dual HD micro-OLED displays, ensuring that both text and 3D imagery are rendered with remarkable sharpness. This feature allows users to seamlessly interact with virtual objects overlaid on their real-world surroundings.

The smart glasses also boast 6DoF (Six Degrees of Freedom) tracking, which allows for fluid and intuitive movement within AR environments. Whether you're a gamer navigating complex digital worlds or a professional utilizing augmented workspaces, the G1 promises smooth and natural interaction.

Next-Level Hardware & Software Integration

The Even Realities G1 features the latest Qualcomm Snapdragon XR2 chipset, a powerful processor specifically designed for AR and VR applications. This allows for enhanced real-time processing and rendering, enabling developers to create more complex and interactive AR environments without latency or performance dips.

Paired with its hardware prowess, the G1 runs on Even Realities OS, a proprietary operating system optimized for AR. The OS is compatible with major AR development platforms like Unity and Unreal Engine, allowing developers to bring immersive apps and games to life with ease. The device is also equipped with AI-powered voice and gesture recognition, ensuring hands-free control for a wide range of applications.

Applications in Professional and Consumer Spaces

The G1 is not just for gaming or entertainment but also aims to disrupt various industries. In the professional space, the glasses can be used for remote collaboration, design, training, and real-time data visualization. Architects, engineers, and medical professionals can benefit from the ability to visualize complex models and data overlaid on physical objects, improving decision-making and efficiency.

For consumers, the G1 promises a new dimension of interactivity in daily life. From AR-enhanced fitness workouts to immersive gaming experiences, the possibilities are limitless. Early reviews from beta testers indicate that the G1’s real-world AR integration offers one of the most lifelike and engaging experiences on the market.

Connectivity and Battery Life

The G1 Smart Glasses offer a robust wireless connectivity suite, supporting Wi-Fi 6E and Bluetooth 5.3, allowing for seamless connection to other devices, including smartphones and computers. This ensures that users can stay connected without compromising on speed or performance.

Battery life has been a significant focus for Even Realities. The G1 provides an impressive 8 hours of continuous use, making it ideal for both personal and professional applications. Fast charging ensures minimal downtime, with the device reaching 80% capacity in under an hour.

Privacy and Safety Features

Even Realities has also addressed concerns surrounding privacy and security in AR devices. The G1 includes advanced privacy settings that allow users to control what data is shared with apps and third parties. Built-in safety features like automatic environmental awareness alert users when obstacles or potential hazards are detected in their surroundings, ensuring a safe AR experience.

Conclusion

Even Realities’ G1 Smart Glasses are set to make waves in the AR world, offering a blend of style, power, and versatility that has yet to be matched. With its sleek design, high-performance hardware, and groundbreaking software features, the G1 is poised to become a frontrunner in both the consumer and professional AR markets.

The G1 Smart Glasses are expected to hit the market by late 2024, with prices starting at $1,199. Pre-orders are already open, and demand is high as tech enthusiasts eagerly anticipate the future of augmented reality.

About Even Realities

Even Realities is a leader in AR technology, known for creating innovative products that push the boundaries of digital and physical integration. The company's focus on user-friendly, high-performance devices has made it a key player in the evolving world of augmented reality.

The United States Patent and Trademark Office has granted Shimano a US patent for a wireless electronic cleat system for cycling shoes. As you ride, the changes the shoe's position in relation to your pedals. With the use of inputs from rider and bike sensors, it enables lateral and fore-aft positioning. These produce data that finds the ideal shoe position and moves there automatically. It is also possible to change manually.

Typically, a pedal, cleat, and shoe connect a rider to their bicycle. An "adjuster" on the sole of the shoe is present in this instance. This is equipped with the cleat, and the shoe attaches to the pedal using the conventional method. With the help of rails, this adjuster's reversible electric motor may move the shoe from front to back and left to right, reports New Atlas.‍

The system's primary battery is located in the pedal, and the shoe, cleat, and adjuster are all powered via a wireless system.

But why such adjustability? Because bicyclists adapt their body position to the many terrains they ride on, including varying uphill and downhill grades. This can alter the legs' pivot points and angles; if the foot's contact point can adapt to compensate, there may be mechanical benefits and improved performance.

Related Walk Faster With These Robotic Shoes

The possible performance advantages of Shimano's adjustable shoes are not yet supported by scientific data, despite their technological promise. “adjusting the anterior-posterior foot position on the pedal does not affect cycling economy in competitive cyclists pedaling at a steady-state power output eliciting approximately 90% of VT [Ventilatory Threshold],” according to a study published in 2023. The results of this study, which was probably carried out in a controlled laboratory setting, imply that the advantages of adjusting foot position may be few, or at the very least, insignificant enough to have no effect on overall performance under steady-state settings.

Google has officially announced the Pixel Watch 3 after months of speculation and leaks. Google’s Pixel Watch has always been a fan favorite for many Pixel phone owners because it kept things within the ecosystem. In fact, Google says that users have “loved the deep integration of Pixel Watches, Pixel Buds, and Pixel phones.”

Pixel Watch 3 is available in two sizes and boasting a slimmer bezel, a brighter screen, advanced fitness training tools, better integration with other Google products and improved power management.

Similar to earlier models, the Pixel Watch 3 tracks a wearer's vitals including oxygen, skin temperature, and heart rate in addition to sleep and stress levels.

Google said these elements of health are related. Sleep and exercise levels affect recovery, and recovery affects the amount of activity a person can perform, repots MobiHealthNews.‍

All of that data is gathered and combined by the Pixel Watch 3 to provide users with a detailed profile that is initially targeted at runners.

The new health features are meant to assist runners in selecting their exercises and in thinking back on their progress.

Related Google: Gemini Will Outshine ChatGPT

With the help of the wearable, users may design their own workout by adding segments, assigning goals to the segments, and establishing intervals.

Using haptic and auditory signals, the wearer receives advice from the gadget as a coach while they run.

Additionally, the watch enables connectivity between devices, including Peloton and NordicTrack training equipment.

Without having to look for settings, users may manage media playback on the exercise screen and follow Google Maps offline.

Google also claims that the Pixel Watch 3 will offer the most precise heart-rate sensing available for runners thanks to recent improvements to its sensing technology.

HR monitoring uses machine learning to measure a user's heart rate and record the wearer's running form. The wearer's form and dynamics, including step cadence, stride height and length, and ground contact time, can also be analyzed by the device.

A user can see performance stats to get ideas on how to get fitter after working out. The watch also evaluates and links the intensity of a workout to the requirement for recovery.

The watch also has a feature called "loss of pulse detection" that feels for a person's pulse. The watch will notify the operator via an automated message and make a call to emergency services if no pulse is detected.  

Additionally, it enters Auto Bedtime Mode, which turns off notifications and detects when the wearer goes asleep. The watch recognizes when a user wakes up and instantly ends Bedtime Mode.

The tech giant also revealed that the Pixel 9, Pixel 9 Pro, and Pixel 9 Pro XL will come equipped with Gemini Live, an AI chatbot that uses generative intelligence. Users can converse freely with the AI chatbot using Live.

Preorders for the Google Pixel Watch 3 are open as of right now, and delivery is scheduled to begin on September 10, 2024. The price of the smaller 41mm device, which is limited to Bluetooth, is $349, while the LTE edition is $449. The cost of the bigger 45mm is $499 for LTE and $399 with Bluetooth.